Search PubMed⌕ Search

Biomedical subjects

J Hayashi

Publications and source records attributed to J Hayashi.

At least 433 records · Page 24Linked to original sources
PubMed1986

Intrafamilial clustering of anti-ATLA-positive persons.

A total of 1,333 persons in 627 families were surveyed for presence of antibody to adult T-cell leukemia-associated antigen (anti-ATLA). Each person was classified according to the anti-ATLA status (positive for sample 1, negative for sample 2) of the head of household of his or her family. In sample 1, the sex- and age-standardized prevalence of anti-ATLA was 38.5%. This was five times as high as the standardized prevalence in sample 2 (7.8%). There were significant differences in prevalence of anti-ATLA between males in samples 1 and 2 and between females in samples 1 and 2. In every age group, prevalence in sample 1 was greater than that in sample 2 except for males aged 60-69 years. In each of four subareas, families in sample 1 had higher standardized prevalence (29.6-42.5%) than families in sample 2 (6.0-9.7%). Although crude prevalence decreased with family size in sample 1 (62.1-25.4%) as well as in sample 2, indirectly standardized prevalence was almost equal within each sample, regardless of number of family members. The degree of aggregation was independent of locality and family size. These data suggest that anti-ATLA-positive persons aggregate in family units.

Antibodies, Viral↗
PubMed1986

Age-specific prevalence of hepatitis B e antigen (HBeAg) and antibody to HBeAg (anti-HBe) among asymptomatic hepatitis B surface antigen (HBsAg) carriers in Okinawa and Kyushu, Japan.

A total of 1,741 asymptomatic hepatitis B surface antigen (HBsAg) carriers in two areas (Okinawa and Kyushu) in Japan were surveyed for the presence of hepatitis B e antigen (HBeAg) and the corresponding antibody (anti-HBe) to determine the age-specific prevalence of these markers and the mean age of carriers with HBeAg. Prevalence of HBeAg was significantly higher in Kyushu (36.4% of 755 carriers) than in Okinawa (20.0% of 986 carriers) (P less than 0.001). The mean age of carriers with HBeAg was 25.5 years in Kyushu and 16.1 years in Okinawa, suggesting that HBeAg converted to anti-HBe earlier in Okinawa than in Kyushu. In contrast, the prevalence of anti-HBe was significantly higher in Okinawa (74.6% of 986) than in Kyushu (56.3% of 755) (P less than 0.001). The prevalence of HBeAg decreased with age up to 40-49 years of age and then increased in both areas. Prevalence of anti-HBe was inversely related to the prevalence of HBeAg in both areas. These data suggest that HBeAg and anti-HBe are chronological markers of chronic hepatitis B virus infection and that the duration of HBeAg persistence can be different in different area, even in the same country.

Age Factors↗
PubMed1986

Myocardial structure in volume-overloaded hearts before and after valve replacement.

The purpose of this study was to evaluate the histological characteristics of left ventricular muscle in volume-overloaded hearts. A preoperative biopsy was obtained in 31 patients: 14 with mitral regurgitation, 14 with aortic regurgitation and 3 with mitral regurgitation and aortic regurgitation. Postoperative tissue samples were available in 15 patients. Histological findings were correlated with echocardiographic and angiographic data before (preop) and one year after (postop) operation. Myocardial cell diameter was correlated with both the end-diastolic (r = 0.77, p less than 0.01) and end-systolic (r = 0.78, p less than 0.01) dimensions of the left ventricle, but was inversely correlated with the end-diastolic wall thickness-to-radius (h/R) ratio (r = -0.71, p less than 0.01). Percent fibrosis increased proportionally to the diameter (r = 0.42, p less than 0.05). For one year after operation, echocardiographic left ventricular dimensions and angiographic left ventricular volumes were significantly reduced (p less than 0.05), but in some patients postoperative values remained greater than normal. With regard to left ventricular morphology, myocardial cell diameter and interstitial fibrosis decreased significantly after valve replacement (p less than 0.05). However, the myocardial fiber remained hypertrophied and interstitial fibrosis remained above normal after surgery. Thus, postoperative ventricular dilatation was dependent upon the degree of myocardial fiber hypertrophy and interstitial fibrosis.

Cardiomegaly↗
PubMed1986

[Clinical evaluation of Cernilton in benign prostatic hypertrophy].

Twenty patients with benign prostatic hypertrophy were treated with Cernilton, 6 tablets a day for an average of 13.2 weeks. Subjective effectiveness was observed in the improvement of sense of residual urine (92%), retardation (86%), night frequency (85%), strain on urination (56%), protraction (53%) and forceless urinary stream (53%). The overall subjective effectiveness was 80% of patients, and the overall objective effectiveness was 54% of patients. Night frequency, residual urine volume and tidal urine volume were improved significantly. The overall effectiveness was 80%. No side effects were observed.

Aged↗
PubMed1986

No significant changes in adult T-cell leukemia virus infection in Okinawa after intervals of 13 and 15 years.

Two separate studies were carried out between 1968 and 1984; a total of 2,021 serum samples from healthy subjects were collected in two districts of Okinawa-on Iriomote Island and in Ishigaki City. The first samples were collected in 1970 on Iriomote Island and in 1968 in Ishigaki City. The second samples were collected after an interval of 13 years in Ishigaki City and after an interval of 15 years on Iriomote Island. These serum samples were tested for the presence of antibody to adult T-cell leukemia-associated antigen (anti-ATLA). The overall prevalence of anti-ATLA in both areas combined was 9.9% from 1968 to 1970 and that from 1981 to 1984 was 8.9%. At both times, anti-ATLA prevalence increased with age and was higher in females than in males. No significant changes in anti-ATLA prevalence was observed: after intervals of 13 and 15 years, the prevalence decreased from 10.2 to 9.9% in Ishigaki City and from 9.4 to 8.2% on Iriomote Island. These data suggest that there has been no significant change in the rate of infection with adult T-cell leukemia virus in recent years in the areas studied.

Adolescent↗
PubMed1986

Effects of normal human fibroblast mitochondrial DNA on segregation of HeLaTG Mitochondrial DNA and on tumorigenicity of HeLaTG cells.

We isolated hybrids and cybrids using HeLaTG cells and human normal primary fibroblasts to examine the functional differences between the mitochondrial genomes of tumor and normal cells with respect to their possible involvement in the regulation of tumorigenicity. Hybrids contained mitochondrial DNA (mtDNA) predominantly from the fibroblast parent and their tumorigenicity was suppressed completely. Then, cytoplasmic transmission of primary fibroblast mtDNA to HeLaTG cells was carried out using toxin-antitoxin selection. Two cybrid clones containing a HeLaTG nucleus only and more than 60% of transmitted fibroblast mtDNA were isolated and injected into nude mice to test their tumorigenicity. They formed tumors when 2 X 10(6) cells were injected, whereas no tumors were formed after injection of 5 X 10(5) cells (a concentration at which HeLaTG subclones formed tumors). These cybrids were cultivated in normal medium for two additional months and the content of fibroblast mtDNA increased gradually, resulting in HeLaTG mtDNA eventually being lost from both cybrid clones. We again examined their tumorigenicity and found that they recovered tumorigenicity completely. These results indicate that tumorigenicity of HeLaTG cells could not be suppressed by replacing their mitochondrial genomes with those of normal primary fibroblasts. Further, the partial suppression of tumorigenicity observed in the cybrid clones was temporary and may be due to cytoplasmic factors other than the mitochondrial genomes. Although we can find no difference between the mitochondrial genomes of normal and tumor cells regarding the regulation of tumorigenicity, the segregation pattern of the mtDNA in the cybrids was of interest: in the absence of any mitochondrial selection, HeLaTG mtDNA was lost while fibroblast mtDNA was retained, even though the nuclear component of these cybrids was from the HeLaTG cells. Thus, there should be some functional differences between the mitochondrial genomes of HeLaTG cells and primary fibroblasts that are responsible for the preferential segregation of HeLaTG mtDNA from the cybrids.

Animals↗
PubMed1985

Absence of extensive recombination between inter- and intraspecies mitochondrial DNA in mammalian cells.

Recombination of mammalian mitochondrial DNA (mtDNA) was examined using mouse X rat somatic cell hybrid clones and rat cybrid clones. The mouse X rat hybrids were isolated by fusion of chloramphenicol-sensitive (CAPs) mouse and CAP-resistant (CAPr) rat cells. The rat cybrids were isolated by fusion of rat cells with type B mtDNA and enucleated cells with type A mtDNA. Genetic and physical analyses showed that the mtDNAs of the hybrids and cybrids were simple mixtures of the two parental mtDNAs except in the following two cases: One was subclone H2-9 of mouse X rat hybrids, which was CAPr even though mtDNA from the CAPs mouse parent was predominantly retained. The other was rat cybrid subclones, Y12-24 and -61, which showed specific loss of one Hinf I fragment of type B mtDNA, B10. These observations suggest that, in contrast to the case with plant mtDNA, recombination of mammalian mtDNA occurs rarely, if at all.

Animals↗
PubMed1985

Prevalence of immunologic markers of hepatitis A and B infection in hospital personnel in Miyazaki Prefecture, Japan.

Between 1980 and 1983, a total of 1,883 serum samples from employees of four prefectural hospitals in Miyazaki prefecture, Japan were surveyed for antibody to hepatitis A virus (anti-HAV) and for the following hepatitis B virus markers: hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs), and antibody to hepatitis B core antigen (anti-HBc). Overall prevalences were 36.9% for anti-HAV, 3.4% for HBsAg, 23.3% for anti-HBs, and 36.6% for anti-HBc. In the control group of 233 healthy persons, prevalences were 51.5% for anti-HAV, 3.0% for HBsAg, 28.3% for anti-HBs, and 33.5% for anti-HBc. No significant difference in the distribution of HBsAg was seen among five work categories. Anti-HBc prevalence was significantly higher in nurses than in office workers (p less than 0.05), other medical personnel (p less than 0.05), and controls (p less than 0.01). The differences between nurses and office workers and other medical personnel became greater with age, but a difference between nurses and the control group was recognized in every age group. A significant difference in the distribution of anti-HBc was seen between surgical physicians (36.7%) and nonsurgical physicians (27.1%). Prevalence of anti-HAV in physicians (32.8%), nurses (29.6%), and laboratory technicians (40.1%) was significantly lower than in the control group (51.5%). These data suggest that in the hospitals studied, hepatitis B is an occupational hazard to nurses and surgical physicians, but that hepatitis A is not.

Adult↗
PubMed1985

Large-scale survey of hepatitis B virus infection in families.

To investigate HBV transmission in families on three islands in Okinawa, Japan, prevalence of HBV markers in two groups of inhabitants was determined. One group consisted of members of families in which there was at least one HBsAg carrier (carrier families); the other group consisted of members of families in which there were no HBsAg carriers (non-carrier families). A total of 3,261 serum samples were collected from subjects on Iriomote Island, Hateruma Island, and Yonaguni Island. These samples were tested for HBsAg by reversed passive hemagglutination (RPHA) and for antibody to hepatitis B core antigen (anti-HBc) by radioimmunoassay. Overall prevalences of HBsAg and anti-HBc were 8.2 and 65.8 per cent respectively. The prevalence of anti-HBC among members of carrier families (80.8%) was significantly higher than that among members of non-carrier families (61.6%) (P less than 0.001). The prevalence of anti-HBc among members of carrier families was higher in all age groups, and was particularly so in children. Within carrier families, the prevalence of anti-HBc was significantly higher in families in which there was at least one HBsAg carrier with HBeAg (94.5%) than in families with no HBeAg-positive carriers (76.1%). This difference was especially marked in young children. These data suggest that in families with HBsAg carrier(s), the risk of transmitting HBV to members, particularly to young children, is higher than in families without carriers, and that the risk is further increased in families with HBeAg-positive carrier(s).

Adolescent↗